Treatments for Hepatitis-C Drugs Harvoni Gilead Sciences

Multi-Class Combination Drugs

Brand Name	Generic Name	Status	Pharmaceutical Company
Harvoni	sofosbuvir + ledipasvir (GS-7977 + GS-5885)	Approved	Gilead Sciences
Viekira Pak	(ombitasvir + paritaprevir + ritonavir) + (dasabuvir)	Approved	AbbVie
Viekirax	ombitasvir (ABT-267) + paritaprevir (ABT-450) + ritonavir	Phase III	AbbVie
n/a	asunaprevir + daclatasvir + BMS-791325	Phase III	Bristol-Myers Squibb
n/a	grazoprevir + elbasvir (MK-8742 + MK-5172)	Phase III	Merck

Pegylated Interferon Alfa

Brand Name	Generic Name	Status	Pharmaceutical Company
PegIntron	peginterferon alfa-2b	Approved	Merck
Pegasys	peginterferon alfa-2a	Approved	Genentech

Mar 21 2015
FDA Update - Important safety information: Harvoni , and Sovaldi‏
Serious and Life-Threatening Cases of Symptomatic Bradycardia as well as One Case of Fatal Cardiac Arrest Reported with Coadministration of amiodarone with either Harvoni® (ledipasvir and sofosbuvir fixed-dose combination) or with Sovaldi® (sofosbuvir) in combination with another direct acting antiviral.

http://www.hepmag.com/drug_list_hepatitisc.shtml

http://hepatitiscnewdrugresearch.com/approved-treatments-for-hepatitis-c.html